Only for Distributors

Inhalation therapy

Inhalation therapy by nebuliser devices
Respiratory diseases can be well managed with inhalation therapy as the dose
reaches the bronchioles and the lung area. Compared with MDIs or dry powder
inhalers, nebulisers allow the medication to be more efficiently deposited with
less coordination problems. Consequently, the medication is uniformly deposited
within the upper and lower respiratory tract where it has maximal effect. Further
advantages are that the airways are moistened and the medicine can be very simply
inhaled. Side effects of treatment are reduced when using inhalation devices
as opposed to MDI and dry powder inhalers as less medication remains in the
mouth, where it has no benefit. Inhalation devices are therefore particularly suitable
for patients with chronic respiratory diseases, children and older patients.